|
|
41
|
|
|
4181BS
|
|
|
BEVIXA 25MG/ML INJ (INC) BEVACIZUMAB (C)
|
|
|
BEVACIZUMAB
|
|
|
BEVIXA
|
|
|
4ML VIAL
|
|
|
C
|
|
|
925.75
|
|
|
925.7524
|
|
|
25MG/ML
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
INC
|
|
|
INCEPTA PHARMACEUTICALS LIMITED
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|